Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-017-3007-9
Published Online: 2017-04-22
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hwang, Yu-Yan
Khong, Pek-Lan
Kwong, Yok-Lam http://orcid.org/0000-0001-8156-6978
License valid from 2017-04-22
